Bookmark
Forward
When the drugs don't work: the potential of glutamatergic antipsychotics in schizophrenia.
The British journal of psychiatry : the journal of mental science 2013 FebSizes of these terms reflect their relevance to your search.
Currently available antipsychotic drugs target dopaminergic neurotransmission. Many patients do not respond fully to these treatments, and there has been considerable effort to investigate alternative targets. Here we summarise the rationale and recent evidence supporting efforts to develop glutamatergic antipsychotic drugs.
Citation
Evangelos Papanastasiou, James M Stone, Sukhi Shergill. When the drugs don't work: the potential of glutamatergic antipsychotics in schizophrenia. The British journal of psychiatry : the journal of mental science. 2013 Feb;202:91-3
Mesh Tags
Substances
PMID: 23377207
View Full Text
